SAVA Q4 2018 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2

Operating Income

-$750,000

Net Income

-$677,000

EPS (Diluted)

$-0.04

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$565,000

Free Cash Flow

-$565,000

Stock-Based Comp.

$403,000

Balance Sheet

Total Assets

$20M

Total Liabilities

$511,000

Stockholders' Equity

$20M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2	-$1,544	+99.9%
Operating Income	-$750,000	-$2M	+69.0%
Net Income	-$677,000	-$2M	+72.0%